15 Results for "

Ruxolitinb

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "Ruxolitinb" in MCE Product Catalog:

280
280 Publications Verification
Cat. No.: HY-50856
CAS No.: 941678-49-5
Synonyms: INCB18424
Research Areas:  

Cancer

Ruxolitinib (INCB18424) is an orally active and selective JAK1/2 inhibitor with IC50s of 3.3 nM and 2.8 nM in cell-free assays, and has 130-fold selectivity for JAK1/2 over JAK3 . Ruxolitinib induces autophagy and kills tumor cells through toxic mitophagy .
loading...
    loading...
280
280 Publications Verification
Cat. No.: HY-50858
CAS No.: 1092939-17-7
Synonyms: INCB018424 phosphate
Target:  

JAK Autophagy Mitophagy

Research Areas:  

Cancer

Ruxolitinib phosphate (INCB018424 phosphate) is a potent JAK1/2 inhibitor with IC50s of 3.3 nM/2.8 nM, respectively, showing more than 130-fold selectivity over JAK3.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-50856A
CAS No.: 941685-37-6
Synonyms: S-Ruxolitinib; S-INCB18424
Target:  

JAK

Research Areas:  

Cancer

Ruxolitinib (S enantiomer) (S-Ruxolitinib) is the S-enantiomer of Ruxolitinib (HY-50856). Ruxolitinib (S enantiomer) is an orally active, potent JAK inhibitor .
loading...
    loading...
Cat. No.: HY-50856S
CAS No.: 1513883-39-0
Synonyms: CTP-543; Ruxolitinib-d8; INCB18424-d8
Target:  

JAK

Research Areas:  

Inflammation/Immunology

Deuruxolitinib (CTP-543; Ruxolitinib-d8) is a deuterated analog of Ruxolitinib (HY-50856) and an orally active, selective inhibitor of JAK1 and JAK2. Deuruxolitinib blocks Janus kinase-mediated cytokine receptor signaling and proinflammatory cytokine gene expression. Deuruxolitinib is primarily metabolized in the liver via CYP2C9. Deuruxolitinib promotes scalp hair regrowth in severe chronic alopecia areata. Deuruxolitinib is used in alopecia areata-related research .
loading...
    loading...
Cat. No.: HY-50856R
CAS No.: 941678-49-5
Synonyms: INCB18424 (Standard)
Research Areas:  

Cancer

Ruxolitinib (Standard) is the analytical standard of Ruxolitinib. This product is intended for research and analytical applications. Ruxolitinib (INCB18424) is a potent and selective JAK1/2 inhibitor with IC50s of 3.3 nM and 2.8 nM in cell-free assays, and has 130-fold selectivity for JAK1/2 over JAK3 . Ruxolitinib induces autophagy and kills tumor cells through toxic mitophagy .
loading...
    loading...
Cat. No.: HY-W062703S
CAS No.: 2469553-67-9
Synonyms: (Rac)-INCB18424-d9; Ruxotinib racemate-d9
(Rac)-Ruxolitinib D9 ((Rac)-INCB18424 D9) is the deuterium labeled (Rac)-Ruxolitinib. (Rac)-Ruxolitinib is a JAK2 inhibitor .
loading...
    loading...
Cat. No.: HY-W062703S1
CAS No.: 1794791-38-0
Synonyms: (Rac)-INCB18424-d8; Ruxotinib racemate-d8
(Rac)-Ruxolitinib-d8 is deuterium labeled (Rac)-Ruxolitinib.
loading...
    loading...
Cat. No.: HY-W059210
CAS No.: 952518-97-7
Research Areas:  

Others

Ruxolitinib impurity-1 is a pyrrolopyrimidine derivative and also an impurity of Ruxolitinib (HY-50856). Ruxolitinib serves as a synthetic intermediate for TDM-180967, a dual JAK1/Tyk2 inhibitor, and can also be used as an impurity reference standard for drug quality control .
loading...
    loading...
Cat. No.: HY-50859
CAS No.: 1092939-16-6
Synonyms: INCB018424 sulfate
Target:  

JAK Autophagy

Research Areas:  

Cancer

Ruxolitinib sulfate (INCB018424 sulfate) is the first potent, selective JAK1/2 inhibitor to enter the clinic with IC50s of 3.3 nM/2.8 nM, and has > 130-fold selectivity for JAK1/2 versus JAK3.
loading...
    loading...
Cat. No.: HY-50856S2
CAS No.: 1513883-55-0
Synonyms: INCB18424-d9
Ruxolitinib-d9 (INCB18424-d9) is deuterium labeled Ruxolitinib. Ruxolitinib (INCB18424) is an orally active and selective JAK1/2 inhibitor with IC50s of 3.3 nM and 2.8 nM in cell-free assays, and has 130-fold selectivity for JAK1/2 over JAK3 . Ruxolitinib induces autophagy and kills tumor cells through toxic mitophagy .
loading...
    loading...
Cat. No.: HY-W722493
CAS No.: 1911644-32-0
Target:  

Drug Derivative

Research Areas:  

Cancer

Ruxolitinib-amide (P28 XII) is an amide derivative of the JAK1/2 inhibitor Ruxolitinib (HY-50856) .
loading...
    loading...
Cat. No.: HY-50858R
CAS No.: 1092939-17-7
Synonyms: INCB018424 phosphate (Standard)
Ruxolitinib phosphate (Standard) is the analytical standard of Ruxolitinib phosphate (HY-50858). This product is intended for research and analytical applications. Ruxolitinib phosphate (INCB018424 phosphate) is a potent JAK1/2 inhibitor with IC50s of 3.3 nM/2.8 nM, respectively, showing more than 130-fold selectivity over JAK3.
loading...
    loading...
Cat. No.: HY-Z18070S
Ruxolitinib M18 metabolite impurity-d4 is the deuterium labeled Ruxolitinib M18 metabolite impurity.
loading...
    loading...
Cat. No.: HY-Z18070AS
(Rac)-Ruxolitinib M18 metabolite impurity-d4 is the deuterium labeled (Rac)-Ruxolitinib M18 metabolite impurity.
loading...
    loading...
Cat. No.: HY-50856BS
CAS No.: 2147706-60-1
Synonyms: CTP-543 phosphate; Ruxolitinib-d8 phosphate; INCB18424-d8 (phospha
Target:  

JAK

Research Areas:  

Inflammation/Immunology

Deuruxolitinib phosphate (CTP-543 phosphate; Ruxolitinib-d8 phosphate) is a deuterated analog of Ruxolitinib (HY-50856) and an orally active, selective inhibitor of JAK1 and JAK2. Deuruxolitinib phosphate blocks Janus kinase-mediated cytokine receptor signaling and proinflammatory cytokine gene expression. Deuruxolitinib phosphate is primarily metabolized in the liver via CYP2C9. Deuruxolitinib phosphate promotes scalp hair regrowth in severe chronic alopecia areata. Deuruxolitinib phosphate is used in alopecia areata-related research .
loading...
    loading...
  • 1